HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brem, R. F. Articles by Wasden, S. Search for Related Content PubMed PubMed Citation Articles by Brem, R. F. Articles by Wasden, S. Social Bookmarking                      What's this?

Lobular Neoplasia at Percutaneous Breast Biopsy: Variables Associated with Carcinoma at Surgical Excision

¹ Department of Radiology, George Washington University, 2150 Pennsylvania Ave., NW, Washington, DC 20037.
² Department of Radiology, Park Nicollet Clinic–St. Louis Park, St. Louis Park, MN.
³ Department of Radiology, Stanford Hospital and Clinics, Stanford, CA.
⁴ Department of Radiology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX.
⁵ Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT.

OBJECTIVE. The purpose of our study was to better define the rate and variables associated with cancer underestimation when lobular neoplasia is found at minimally invasive breast biopsy.

MATERIALS AND METHODS. The records of 32,420 patients who underwent imaging-guided needle biopsy of the breast for mammographic or sonographic abnormalities from 1988 to 2000 were retrospectively reviewed. The 278 cases in which lobular neoplasia was the highest-risk lesion at biopsy were included. Of the 278 cases, 164 proceeded to surgical excision, allowing calculation of rates of underestimation from minimally invasive biopsy.

RESULTS. Of the 32,420 minimally invasive breast biopsies, lobular neoplasia was found in 278 (0.9%). One hundred sixty-four of the 278 (59%) continued to surgical excision, where cancer was pathologically confirmed in 38 (23%). No difference was seen in the underestimation rates for lesions diagnosed as lobular carcinoma in situ (25%, 17 of 67 lesions) versus atypical lobular hyperplasia (22%, 21 of 97 lesions). Statistically significant underestimation of carcinoma was found with biopsy of masses (with or without associated microcalcifications) rather than calcifications only, a higher BI-RADS category (p < 0.0001), use of a core biopsy device rather than a vacuum device (p < 0.01), and obtaining fewer specimens (p < 0.0001).

CONCLUSION. Significant sampling error occurs regardless of the type of core biopsy device, number of specimens obtained, histologic–radiographic concordance, mammographic appearance, and complete excision of the lesion as determined by imaging. For this reason, all patients with lobular neoplasia at core or vacuum-assisted biopsy should undergo surgical excision until further differentiating criteria can be determined.

Keywords: breast imaging • biopsy • lobular neoplasia • mammography

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. B. Kopans LCIS Found at Core Needle Biopsy May Not Need Surgical Excision Am. J. Roentgenol., September 1, 2008; 191(3): W152 - W152. [Full Text] [PDF]

				R. F. Brem, R. J. Jackman, and M. C. Lechner Reply Am. J. Roentgenol., September 1, 2008; 191(3): W153 - W153. [Full Text] [PDF]

				M. F. Dillon, E. W. Mc Dermott, and C. M. Quinn Management of B3 Lesions and Breast Biopsies Ann. Surg. Oncol., July 1, 2008; 15(7): 2055 - 2056. [Full Text] [PDF]